ovarian-cancer

Ovarian cancer is known as a "silent killer" because it is usually discovered too late to save a woman's life.

It was the first mummy to be subjected to a scientific autopsy, and Granville concluded that she died of ovarian cancer.

Because of her work, Cooney knew to ask for palliative care when she was diagnosed with advanced ovarian cancer nearly three years ago.

Initial testing of a vaccine for ovarian cancer that strengthens the body's natural immune response is showing encouraging results.

A blood test which would detect the early stages of ovarian cancer could be less than two years away.

Conclusion Color Doppler flow imaging examination is an effective preoperative diagnosis of ovarian cancer, one of the methods.

Chemotherapy improves survival and is an effective means of palliation of ovarian cancer.

Ovarian cancer looks like a good candidate for screening as symptoms often do not appear until it is too advanced to treat.

Certain versions of these genes, it has been shown, are associated with a high risk of breast and ovarian cancer.

Since the funeral (ovarian cancer), she was just your mother.

"Even though we see a 2- to 3-fold increase in the risk for ovarian cancer, it's still a very rare condition, " she said.

One of my best friends was diagnosed with metastatic ovarian cancer, one month before her senior prom and one year before she would die.

But when they're combined, if either one is positive, we might be able to identify 80. 6% of women with early stage ovarian cancer.

A majority of women with ovarian cancer will face recurrent disease despite receiving aggressive chemotherapy at the time of diagnosis.

Activation of ODC resulting from MTAP deletion may be one of the pathogenetic factors of ovarian cancer.

The objective of this artical is to discuss the changes in ovarian cancer treatment concept, excessive and inadequate surgical treatment.

Objective: Ovarian cancer is one of the leading cause of death among all gynecologic malignancies.

Myriad Genetics was the first company to identify two genes that can greatly increase a woman's risk of breast and ovarian cancer.

A few simple questions may help women identify the early, often quiet, symptoms of ovarian cancer.

Ovarian cancer is one of the most common gynecological malignancy with high mortality.

This increases her risk of breast cancer, ovarian cancer and of developing cardiovascular problems.

In the next month, the end of December, you'll see ovarian cancer, and then lung cancer will come several months after.

Additional risk factors are a personal history of breast or ovarian cancer, AGE (over AGE 40), and a family history of uterine cancer.

A soluble form of mesothelin has been detected in patients with ovarian cancer and malignant mesothelioma, and has prognostic value.

The over-expression of SRC-3 protein may be one of the molecular markers in predicting the malignancy of ovarian cancer.

Results: The differentiation were significant among the patients with ovarian cancer, benign ovarian tumor and normal controls(P01).

While it was already known that the pill reduces the risk of ovarian cancer, the magnitude and duration of the effect has remained unclear.

Evelyn Lauder, who died of complications from non-genetic ovarian cancer on Saturday, had a swarm of close friends throughout her life.

Objective: To determine the expression and significance of lung resistance protein (LRP) in epithelial ovarian cancer.

Uterine cancer, ovarian cancer and testicular cancer are prevented due to the removal of the susceptible organs.

A. Palpation of an asymptomatic adnexal mass during a routine pelvic examination is the usual presentation for ovarian cancer.

Researchers have found that these symptoms are more likely to happen in women with ovarian cancer then women in general.

Researchers have found that these symptoms are more likely to happen in women with ovarian cancer than women in general.

Further follow-up should help us determine if these approaches can be cost-effective and truly reduce deaths from ovarian cancer.

The American Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial found no survival benefit for screening.

Moreover, the authors asked whether LDN can be combined with standard chemotherapy to invoke an even greater effect on ovarian cancer.

Ovarian cancer has been challenging to treat because it tends to recur frequently and develop resistance to treatment.

Cases with ovarian cancer were eligible if they had had a serum sample banked before pathological staging by a gynaecological oncologist.

The signs and symptoms of ovarian cancer may be only those of an enlarging tumor in the pelvis.

The Pill is now known to have some health benefits, including reducing the risk of uterine and ovarian cancer.

The statement is the first of its kind to recognize what ovarian cancer survivors have long believed: that there are common symptoms.

A study in Australia found that women's risk for ovarian cancer increased as a result of eating processed meats.

Three-dimensional power Doppler ultrasound improves the diagnostic accuracy for ovarian cancer prediction.

Lauder died Saturday at her Manhattan home from complications of nongenetic ovarian cancer. She was 75.

Treatments for ovarian cancer have become more effective in recent years, with the best results seen when the disease is found early.

Can also be precise and effective traps, and produce genetic ovarian cancer cells genetic ovarian cancer antibodies.

Conclusion Arsenic trioxide inhibits cell proliferation, induces apoptosis in ovarian cancer cell.

Finally, they tested the approach in mice with an ovarian cancer cell line known to be resistant to taxane-based drugs such as docetaxel.

Ovarian cancer is particularly deadly because women often have mild or no symptoms until the disease has progressed.

Water-like leucorrhea: malignant tumor or ovarian cancer, oviduct cancer early will appear in the phenomenon of increased leucorrhea.

To investigate the efficacy and toxicity of oxaliplatin-based chemotherapy in the treatment of epithelial ovarian cancer (EOC) .

During pregnancy and lactation, breast cancer, ovarian cancer, uterine cancer, allergies are disabled.

It has been reported that AMD has therapeutic action for cancer of the cervix and ovarian cancer.

Objective: To observe the role of Panax ginseng polysaccharide injection in chemotherapy of patients with ovarian cancer.

Objective To evaluate the value of FPM intraperitoneal chemotherapy regimen before operation on advanced ovarian cancer with ascites.

Objective to search the differential expressed proteins from ovarian cancer serum for diagnosis of ovarian cancer .

Unfortunately, there's only one sure way for doctors to know if a woman has ovarian cancer: surgery.

However, the optimal timing (TI) of postoperative chemotherapy for ovarian cancer remains poorly defined.

This page presents ovarian cancer survival statistics including survival trends over time, by stage at diagnosis and by age.

The case was brought by Myriad Genetics, which wants to patent two genes that help forecast the risk of breast and ovarian cancer.

The incidence of the spread of ovarian cancer after laparoscopic surgery is difficult to establish from the current literature.

OBJECTIVE: To provide the clinician with current concepts regarding prevention of ovarian cancer.

"There may be an important link with breast and ovarian cancer, " Stanhope says.

Worldwide, much effort goes into performing optimal surgery in treatment of epithelial ovarian cancer (EOC).

ConclusionDisease uncertainty truly affects toxic and side effect scores of chemical therapy among epithelial ovarian cancer patients.

Symptoms suggesting ovarian cancer and details of operation performed to remove the foreign body are described.

The expression of lung resistance protein in primary epithelial ovarian cancer a nd its clinical significance .

Study the effects on treating and preventing rat epithelial ovarian cancer by photodynamic tumor vaccines in vivo.

Both forms of HRT increase the risk of ovarian cancer, although not by as much as they do breast cancer.

As in other studies, several cases in this series were initially diagnosed as ovarian cancer because of a pelvic mass with ascites.

Color Doppler flow imaging; Preoperative diagnosis; Ovarian cancer.

are more likely to happen in women with ovarian cancer than women in general.

ABSTRACT: Objective To assess the effects of platelet and fibrinogen on progressive ovarian cancer.

An overview of the literature on the role of gemcitabine in the treatment of epithelial ovarian cancer is also presented.

Talc can be extremely dangerous and has been proven to cause ovarian cancer and this powder is TALC-FREE.

Ovarian cancer is responsible for more deaths per annum than cervical and endometrial cancer combined.

An important determinant of ovarian cancer survival is the stage of the disease at diagnosis.

The pill appears to reduce the risk of ovarian cancer, even long after women stop taking it, concludes an analysis in the Lancet.

VEGF-C in human ovarian promoted tumor cell proliferation, invasion and metastasis, was related to epithelial ovarian cancer prognosis.

The main research directions are etiology and the prevention research of lung cancer and ovarian cancer in the present.

Also, researchers say women with early-stage ovarian cancer may urinate more often or with greater urgency.

There's some evidence that regular exercise also reduces the risk of lung, prostate and ovarian cancer, she says.

Ovarian cancer is the most lethal gynaecological cancer and ranks as the 6th most common cause of cancer death in Australian women.

Comparative studies of ovarian cancer mortality in Scotland also indicate this.

The positive rate expressed by CD68marked macrophage in ovarian cancer is significantly higher than in benign and borderline ovarian tumor.

abstract: Objective To explore the effects of divalent cation on adhesion, invasion and metastasis of human SKOV3 ovarian cancer cells.

33 cases had been subjected to surgeries or relapsed after chemo therapies, and 4 were primary ovarian cancer.

The invention comprises the use of leptin, prolactin, OPN and IGF-II for diagnosing, prognosis and monitoring of ovarian cancer.

A. Cytoreductive surgery improves response to chemotherapy and survival of women with advanced ovarian cancer.

Also, researchers say women with early stage of ovarian cancer may # more often or with # agency.

Scientists have identified a genetic flaw which can increase the risk of ovarian cancer.

Taxol is the world's emerging bio-extract anticancer drugs on ovarian cancer and breast cancer has good efficacy.

Previous studies have shown that soya and tofu cut the risk of ovarian cancer and heart disease.

A federal judge on Monday struck down patents on two genes linked to breast and ovarian cancer.

Objective: To explore the expression of CA125 and CA199 in epithelial ovarian cancer and endometriosis discuss its clinical significance.

In the last 30 years, we haven't done a lot to improve the overall survival of ovarian cancer patients.

Objective: To observe the effect of cryosurgery on recurrent ovarian cancer at vaginal residue.

The positive rate expressed by MCP-1 in ovarian cancer is significantly higher than in benign and borderline ovarian tumor.

A previous IUD user underwent surgery on suspicion of ovarian cancer.

What do endometriosis and ovarian cancer have in common?

What do endometriosis and ovarian cancer have in common?

Worldwide there are more than an estimated new cases of ovarian cancer each year, a disease more common after age 50.

His team also examined phenethyl isothiocyanate (PEITC), a constituent of cruciferous vegetables such as broccoli, on ovarian cancer cells.

But these were tests that were supposed to find ovarian cancer in patients' blood.

In the US, ovarian cancer is the fifth leading cause of cancer deaths in women.

Some experimental evidence show MGC5306 gene involves in the ovarian cancer.

Don't worry about taking the pill when you are young. It protects against ovarian cancer.

D. , a post-doctoral research fellow at the University of Pennsylvania Ovarian Cancer Research Center.

In 1996, when John Major was in power, my mother was diagnosed with ovarian cancer.

A new US medical study found that a diet low in fat could reduce the risk of ovarian cancer in postmenopausal women.

Ovarian cancer is a malignant tumour in the ovary .

"Ovarian cancer, " I say, very quietly.

The study also found that the women who had ovarian removal lowered their risk of death from ovarian cancer by almost eighty percent.

This article reviews recent progresses of gene chip technique in ovarian cancer study in order to have a further full view. . .

Does HRT Increase Risk for Ovarian Cancer?

For the 14 patients with ovarian cancer, the median time to progression was two months and the median overall survival was 15 months.

What are risk factors for ovarian cancer?

Sandra Cohen has never had breast cancer or ovarian cancer. But she has the BRCA1 and BRCA2 mutations.

Table 1 shows the estimated absolute risk for ovarian cancer before age 75 in never-users and ever-users.

Taller women have a slightly higher risk of ovarian cancer, according to a review of studies.

Women who undergo hysterectomies often have both ovaries removed along with the uterus in order to prevent ovarian cancer.

Ovarian cancer is a common gynecologic malignancy that usually can not be detected at early stage.

Ovarian cancer mortality in the highest of all gynecological tumor, cervical cancer and more than the sum of endometrial cancer.

However, use of birth control pills also decreases the risk of other types of cancer, such as ovarian cancer and endometrial cancer.

Women who have relatives with ovarian cancer and other adenocarcinomas have relative risks of ovarian cancer of 3 and 1. 5 respectively.

Around 6, 700 women in the UK are diagnosed with ovarian cancer each year.

The second case concerns pseudo Meigs syndrome at 57-year old woman, who was operated because of ovarian cancer.

Nearly 14, 000 women are expected to die of ovarian cancer in 2010, according to the NCI.

Objective To study the clinical value of the quantities and the activity of tissue factor pathway inhibitor (TFPI) in ovarian cancer.

Objective To study the value of treatment of the vaginal ultrasound-guided biopsy in diagnosis of advanced ovarian cancer.

Objective To study the mental status and its effect on the cell immunity in the patients with ovarian cancer.

Objective To study the value of intraperitoneal chemotherapy after operation on the patients with ovarian cancer.

AIM To study the effect of inhibition of telomerase activity by reverse transcriptase inhibitors (AZT) on ovarian cancer cells in vitro.

Ovarian cancer is the seventh leading cause of female cancer deaths in Hong Kong.

Objective To study the clinical significance of determination of serum TNF and IL-8 levels in patients with ovarian cancer.

ovarian cancer is often asymptomatic at early stage

The correlations between the incidence rates of ovarian cancer and animal food consumption as well as the birth cohort research of death

Identification of serum biomarkers for ovarian cancer using protein chips and time of flight mass spectrometry technology

Experimental Study of Energy Controllable Steep Pulses Inhibiting Growth of Xenografted Tumor of Ovarian Cancer Cells

Experimental Study of Anti-VEGF Hairpin Ribozyme Gene Inhibiting Expression of VEGF and Proliferation of Ovarian Cancer Cells

Experimental Study of Anti-VEGF Hairpin Ribozyme Gene Inhibiting Expression of VEGF and Proliferation of Ovarian Cancer Cells

The levels of TSGF in the patients with epithelial ovarian cancer than those with any other types of ovarian cancer;

Study of HLA molecules and its associated genes expression in human ovarian cancer cells

Relations between the expression of VEGF and its receptor KDR and the progression of epithelial ovarian cancer

Expression of Urokinase-type Plasminogen Activator Receptor in Epithelial Ovarian Cancer and its Significance

Characteristic of retroperitoneal lymph node metastasis of ovarian cancer and its clinical significance

Correlation of the expression of plasminogen activation system with the occurrence, development and prognosis of ovarian cancer

A Clinical Study of Intraperitoneal Chemotherapy After Operation on Patients with Ovarian Cancer

The relationship between the expression of vascular endothelial growth factor and tumor angiogenesis in ovarian cancer

The association between the residual size of ovariotomy and prognosis in advanced epidermic ovarian cancer

The different prognostic significance of platinum-based intraperitoneal chemotherapy in advanced epithelial ovarian cancer

Indwelling intravenous cannula for intraperitoneal chemotherapy of postoperative ovarian cancer

Ultrasonographic Characteristics of Recurrent and Metastatic Ovarian Cancer and Their Clinical Significance

Suicidal cancer vaccine enhances anti-tumor immunotherapeutic effect and its safety in the treatment of ovarian cancer

Comparative proteomics analysis of differentially expressed metastasis-associated proteins in human ovarian cancer cell lines

Detection of micrometastases in pelvic lymph nodes of patients with ovarian cancer and its clinical significance

Application of a Micromethod in Ovarian Cancer Chemosensitivity Testing in vitro

Observation of the Treatment Using Taxotere Associate with Carboplatinum in Ovarian Cancer Chemotherapy

A Study of Influence Factors on Treatment and Prognosis in Patients with Epithelial Ovarian Cancer

Genetic algorithm-partial least squares algorithm as the feature selection method for proteomics data of ovarian cancer

Expressions of vascular endothelial cell growth factor and its receptor mRNA in epithelial ovarian cancer

Clinical observation on Combined intraperitoneal and intravenous chemotherapy in the treatment of epithelial ovarian cancer

Combination of cisplatin with oral etoposide and hexamethylmelamine in treatment of platinum-sensitive recurrent ovarian cancer

Characterization of TAXOL-resistance ovarian cancer cell lines induced by different administrations approaches

Multicenter clinical research of chemotherapy with topotecan and cisplatin in patients with advanced epithelial ovarian cancer

Correlation between chemosensitivity of anticancer drugs and telomerase activity in human epithelial ovarian cancer cell lines

Application of ATP-bioluminescence Assay for Screening Chemotherapeutic Agents of Ovarian Cancer Chemotherapy

Comparative Study on three Chemotherapeutic Regimens for the Treatment of Advanced Epithelial Ovarian Cancer

OPCML gene transferred by recombinant lentiviruses in vitro and its inhibition to ovarian cancer cells

Prognosis of Qi-Deficiency and Blood-Stasis Ovarian Cancer and Its Correlativity with Angiogenesis in Rats

Correlation between ATP bioluminescence tumor chemosensitivity assay and clinical response in ovarian cancer

Clinical study of urokinase-type plasminogen activator mRNA in ovarian cancer

Antisense Oligonucleotide Reverses Topotecan-Resistant Ovarian Cancer Cells

Primary Study of Microsatellite Instability in Ovarian Cancer

Expression of Lung Resistant-Related Protein in Ovarian Cancer and Its Clinical Significance

Correlation of Chemosensitivity to Anticancer Drugs and Telomerase Activation in Human Epithelial Ovarian Cancer Cell Lines

Nursing Care for the Ovarian Cancer Patients after surgery with Remained Intraperitoneal Chemotherapy Tube

Influence of gonadotropin-releasing hormone agonist on the effects of chemotherapy upon ovarian cancer: an experimental study with rat model

Construction and preliminary selection and identification of phage display library of anti-human ovarian cancer single chain Fv antibody

Comparison Between Apoptosis Cells Count and ATP-Bioluminescence Assay in Ovarian Cancer Chemosensitivity Testing in vitro

Preparation of Anti-human Endoglin Single-Chain Antibody and Its Radioimmunoimaging within Human Ovarian Cancer Bearing Nude Mice

Study of cell adhesion drug resistance of ovarian cancer mediated by fibronectin

A Rational Selection of Retroperitoneal Lymphadenectomy for Advanced Epithelial Ovarian Cancer

Application of a Risk of Malignancy Index in Pre-operative Diagnosis of Ovarian Cancer

Experimental study of endocrinotherapy of human ovarian cancer cell in vitro

The Studies of Preliminary Application on cDNA Microarray for Early Diagnosis and Clinicopathologic Staging of Ovarian Cancer

Relationship between expression of tumor adhesion molecules and drug resistance of ovarian cancer chemotherapy

Correlation Between Thrombocytosis and Advanced Epithelial Ovarian Cancer

Psychological influence of Neoadjuvant chemotherapy on patients with advanced ovarian cancer and nursing

Clinical Research on the Treatment of Primary Ovarian Cancer with Operation, Chemotherapy and Traditional Chinese Herbs

Clinical Research on Preoperative Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

Comparison of drug resistance related genes expressions between primary and metastatic sites in patients with ovarian cancer

Application of Intraperitoneal Chemotherapy for the Initial Treatment of Ovarian Cancer

WWOX mRNA expression in epithelial ovarian cancer and its clinical significance

Preliminary Analysis of the Expression of Three MAGE Family Genes in Human Ovarian Cancer and the HLA Phenotype Analysis of Patients

Experimental study on apoptosis of ovarian cancer cells and reversal docetaxel drug resistance induced by Survivin antisense RNA

Evaluation on intraperitoneal and intravenous chemotherapy of Taxol plus cisplatin in advanced ovarian cancer

Preliminary study on pathway of follicle-stimulating hormone on human epithelial ovarian cancer cell proliferation

Cloning of Expression Vector of Human Tissue Factor Gene and its Expression in Human Ovarian Cancer Cell Line

Nursing coordination of double - paths therapy applied in ovarian cancer patients underwent total correction

Protocol of Paclitaxel Plus Carboplatin Treating Advanced and Recurrent Epithelial Ovarian Cancer

Multiple Cycles of High-Dose Chemotherapy with Peripheral Blood Stem Cell Support in the Treatment of Relapsed or Refractory Ovarian Cancer

Observation on Efficacy of Surgery and Intraperitoneal Chemotherapy by Subcutaneous Pump in Patients withAdvanced Epithelial Ovarian Cancer

Expression and implication of metallothionein and lung resistance protein in epithelial ovarian cancer

Correlation of chemosensitivity to anticancer drugs and PCNA expression in human epithelial ovarian cancer cell lines

Study on the inhibition of 11 Cytotoxic Drugs on the Ovarian Cancer Cells and its Relationship with the Effects on the Nucleated Cells

Expression of heparanase in ovarian cancer and its clinical significance

Preliminary observation for high intensity focused ultrasound in the treatment of subcutaneous ovarian cancer of nude mice

Comparison of two managements of epithelial ovarian cancer with ascites

Follicle Stimulating Hormone Inhibits Cisplatin Induced Apoptosis in Ovarian Cancer Cells

Effects of medicated rat serum of traditional Chinese herb decoction on proliferation of ovarian cancer fresh solid tumor cells

Relationship between Lung Resistance Protein and Resistance Phenotype of Ovarian Cancer to Cisplatin

Preoperational misdiagnosis of extragastrointestinal stromal tumors as ovarian cancer: report of three cases with literature review

Analysis of proteomic fingerprint patterns of ovarian cancer cell lines with different invasive potential

Effect of a risk of malignancy index in preoperative diagnosis of ovarian cancer

Clinical significance of hepatocyte growth factor and c-met expressions in patients with epithelial ovarian cancer

Value of PCNA Expression in Predicting Advanced Epithelial Ovarian Cancer Chemotherapy Efficiency

Molecular mechanism of apoptosis in cisplatin-resistant human ovarian cancer cell lines promoted by topotecan

Evaluation of the value of chemotherapy before operation in the management of advanced epithelial ovarian cancer

Impact of whole abdomen radiation therapy integrated in the management of recurrent epithelial ovarian cancer

Clinical research of chemotherapy with topotecan and cisplatin in patients with advanced ovarian cancer

Nursing of Ovarian Cancer Patients with Chemiotherapy by Single Peritoneocentesis

Combination of Continuous Hyperthermic Peritoneal Perfusion and High Frequency Diathermy for 28 Patients with Advanced Ovarian Cancer

Study on the optimal choice of therapeutic approaches for elderly women with advanced epithelial ovarian cancer

Preparation of a controlled live DC vaccine of rat ovarian cancer in vitro

Concentration levels of serum RANTES in patients with ovarian cancer and their clinical significance

The Expression role of acetyl-heparanase, laminin and laminin receptor and their role in the metastasis of ovarian cancer

Morphological changes of mitochondria in apoptosis of human ovarian cancer cells induced by arsenic trioxide in vitro

Relationship of cyclooxygenase- 2 expression and chemotherapy resistance in epithelial ovarian cancer patients

Expression of Extracellular Signal-regulated Kinase in Epithelial Ovarian Cancer

Clinical Pharmacodynamics of Paclitaxel in Patients with Advanced Ovarian Cancer

Administration Analysis of Ancient Prescription in Treating Ovarian Cancer

Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potential

Clinical Efficacy Analysis of Chemotherapy to Lymph Node Metastasis in Epithelial Ovarian Cancer

Comparison of Therapeutic Efficacy between TP Regimen and CBP Regimen on Epithelial Ovarian Cancer after Optimal Cytoreductive Operation

Expression of Survivin Ki67 in human primary and metastatic ovarian cancer and its clinical implication

Establishment and characterization of an epithelial ovarian cancer animal model in fischer 344 rats

Curative Effect Observation of Native Paclitaxel for Ovarian Cancer and Endometrial Cancer

Expression of apoptosis-associated proteins and drug resistance in patients with ovarian cancer

Intraperitoneal chemotherapy for ovarian cancer

Immunohistochemical study on dendritic cells in epithelial ovarian cancer

Comprehensive Therapy and Prognosis of Advanced Epithelial Ovarian Cancer

Expression of PTEN protein and clinicopathological significance in tumorigenesis and progression of ovarian cancer

Relief of paclitaxel-induced arthralgia and myalgia with oral prednisone in patients with ovarian cancer

Expression of Intercellular Adhesion Molecule 1 and its Effects on Adhesion and Invasion of Ovarian Cancer

A Clinical Study of Maximum Cytoreductive Surgery for Advanced Ovarian Cancer

Influence factors of distant metastases after treatment in epithelial ovarian cancer

Clinical study on advanced ovarian cancer by chemotherapy combined with radiotherapy

The "predictive molecule targeted chemotherapy" for relapsed ovarian cancer-a pilot study

Alterations of mitochondrial DNA in ovarian cancer patients with and without chemotherapy